×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Side Effect Management

Barbara Tako
This two-time cancer survivor is worn out, but not quitting.
Jane Biehl, Ph.D.
I usually got the infections first, so my oncologist loaded me up with antibiotics and off I went. She knows that not going would cause such a depression that I would be worse.
Barbara Tako
Pain management or cost management? Which local surgical anesthetic will your hospital use?
Karyn Dyehouse, M.D.
Under Medicare’s new oncology care model, patient-centric treatment aims to save money while improving health outcomes.
Kristie L. Kahl
The Food and Drug Administration (FDA) approved Leukine (sargramostim) for the treatment of adult and pediatric patients who are exposed to myelosuppressive doses of radiation that results in a hematopoietic subsyndrome of acute radiation syndrome.
Christopher Pirschel
Mobile apps may help teens and young adults stick with their medication schedules, a nurse scientist finds.
Kristie L. Kahl
The Food and Drug Administration (FDA) approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to reduce the risk for febrile neutropenia in patients treated with chemotherapy in certain types of cancer.
Brielle Urciuoli
Insomnia is a common issue that many patients and survivors face. However, cognitive behavioral therapy and acupuncture was proven to be helpful in a recent study.
Bonnie Annis
Residual pain after breast cancer can be cancer-related fatigue. Learn more about the signs and symptoms from this survivor.
Kristie L. Kahl
In this week’s episode of CURE Talks Cancer, we spoke with Matt Lashey, creator and CEO of the chemoWave app, which is designed to manage cancer symptoms and conditions by keeping track of a patient’s overall well-being to understand how their experiences may be related to feeling better or worse during treatment. 
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other